NYSE:BOAC

Bluescape Opportunities Acquisition Competitors

$10.10
+0.06 (+0.60 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.01
Now: $10.10
$10.13
50-Day Range
$9.75
MA: $10.10
$10.78
52-Week Range
$9.51
Now: $10.10
$13.09
Volume71,762 shs
Average Volume265,082 shs
Market Capitalization$766.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Bluescape Opportunities Acquisition (NYSE:BOAC) Vs. AJAX, AJAX, PNTM, BTWN, CMLF, and VYGG

Should you be buying BOAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Bluescape Opportunities Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Pontem (PNTM), Bridgetown (BTWN), CM Life Sciences (CMLF), and Vy Global Growth (VYGG).

Ajax I (NYSE:AJAX) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent ratings for Ajax I and Bluescape Opportunities Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Bluescape Opportunities Acquisition0000N/A

Profitability

This table compares Ajax I and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares Ajax I and Bluescape Opportunities Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Ajax I (NYSE:AJAX) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.

Profitability

This table compares Ajax I and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares Ajax I and Bluescape Opportunities Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings for Ajax I and Bluescape Opportunities Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Bluescape Opportunities Acquisition0000N/A

Pontem (NYSE:PNTM) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Valuation and Earnings

This table compares Pontem and Bluescape Opportunities Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PontemN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Pontem and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PontemN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Pontem and Bluescape Opportunities Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pontem0000N/A
Bluescape Opportunities Acquisition0000N/A

Bridgetown (NASDAQ:BTWN) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

Profitability

This table compares Bridgetown and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares Bridgetown and Bluescape Opportunities Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Bridgetown and Bluescape Opportunities Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Bluescape Opportunities Acquisition0000N/A

Bluescape Opportunities Acquisition (NYSE:BOAC) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Profitability

This table compares Bluescape Opportunities Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Valuation and Earnings

This table compares Bluescape Opportunities Acquisition and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Bluescape Opportunities Acquisition and CM Life Sciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
CM Life Sciences0000N/A

Bluescape Opportunities Acquisition (NYSE:BOAC) and Vy Global Growth (NYSE:VYGG) are both small-cap unclassified companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Analyst Ratings

This is a summary of current ratings and recommmendations for Bluescape Opportunities Acquisition and Vy Global Growth, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
Vy Global Growth0000N/A

Profitability

This table compares Bluescape Opportunities Acquisition and Vy Global Growth's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
Vy Global GrowthN/AN/AN/A

Valuation and Earnings

This table compares Bluescape Opportunities Acquisition and Vy Global Growth's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
Vy Global GrowthN/AN/AN/AN/AN/A


Bluescape Opportunities Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.03+0.3%$897.11 millionN/A0.00Increase in Short Interest
News Coverage
Ajax I logo
AJAX
Ajax I
0.0$10.03+0.3%$897.11 millionN/A0.00Increase in Short Interest
News Coverage
PNTM
Pontem
0.0$9.78+0.3%$843.53 millionN/A0.00
BTWN
Bridgetown
0.0$10.72+0.2%$797.29 millionN/A0.00
CMLF
CM Life Sciences
0.0$13.94+2.8%$771.50 millionN/A0.00Gap Up
VYGG
Vy Global Growth
0.0$10.26+0.1%$737.44 millionN/A0.00
BOWX
BowX Acquisition
0.0$12.07+9.0%$728.73 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.50+0.1%$675.94 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.13+0.3%$671.56 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$14.39+9.1%$629.56 millionN/A0.00Gap Down
ACIC
Atlas Crest Investment
0.0$9.92+0.3%$620 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.84+0.1%$615 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.53+0.0%$583.10 millionN/A0.00
VSPR
Vesper Healthcare Acquisition
1.7$10.10+1.8%$580.75 millionN/A0.00Decrease in Short Interest
News Coverage
Gap Down
VAQC
Vector Acquisition Corp II
0.0$9.95+0.3%$570.63 millionN/A0.00Quiet Period Expiration
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.11+0.3%$569.19 millionN/A0.00News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$9.99+0.1%$561.94 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.85+0.5%$517.83 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.03+6.7%$515.09 millionN/A0.00High Trading Volume
News Coverage
Gap Down
MOTV
Motive Capital
0.0$9.90+0.5%$512.33 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.85+0.2%$509.74 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.14+1.5%$507 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.86+0.4%$504.96 millionN/A0.00
Supernova Partners Acquisition logo
SPNV
Supernova Partners Acquisition
0.0$9.99+0.1%$502.63 millionN/A0.00Increase in Short Interest
EPHY
Epiphany Technology Acquisition
0.0$9.83+0.1%$502.43 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.95+0.1%$500.61 millionN/A0.00High Trading Volume
GMII
Gores Metropoulos II
0.0$10.00+0.0%$500 millionN/A0.00
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.83+0.0%$494.58 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$10.95+0.4%$492.75 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.20+0.4%$470.22 millionN/A0.00News Coverage
NGAC
NextGen Acquisition
0.0$9.90+0.0%$464.06 millionN/A0.00Increase in Short Interest
HIGA
H.I.G. Acquisition
0.0$9.97+0.1%$453.57 millionN/A0.00Decrease in Short Interest
News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$10.36+1.6%$446.78 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$7.00+0.3%$445.20 millionN/A0.00Increase in Short Interest
LUXA
Lux Health Tech Acquisition
0.0$10.23+0.4%$441.17 millionN/A0.00Decrease in Short Interest
News Coverage
ACII
Atlas Crest Investment Corp. II
0.0$10.09+0.2%$435.13 millionN/A0.00
GHVI
Gores Holdings VI
0.0$12.60+1.6%$434.70 millionN/A0.00
FSRV
FinServ Acquisition
0.0$13.52+0.5%$431.49 millionN/A0.00News Coverage
RMGB
RMG Acquisition Co. II
0.0$9.98+0.2%$430.39 millionN/A0.00News Coverage
CAP
Capitol Investment Corp. V
0.0$9.91+0.1%$427.37 millionN/A0.00News Coverage
KURI
Alkuri Global Acquisition
0.0$9.88+0.2%$426.08 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.88+0.2%$426.08 millionN/A0.00
DHHC
DiamondHead
0.0$9.82+0.3%$423.49 millionN/A0.00
CBAH
CBRE Acquisition
0.0$9.98+0.0%$421.79 millionN/A0.00
FTCV
Fintech Acquisition Corp. V
0.3$12.03+3.0%$411.27 millionN/A0.00Gap Down
PCPC
Periphas Capital Partnering
0.0$24.26+1.7%$407.71 millionN/A0.00
SWBK
Switchback II
0.0$10.06+0.2%$397.68 millionN/A0.00
NSTB
Northern Star Investment Corp. II
0.0$9.91+1.3%$396.40 millionN/A0.00
RAAC
Revolution Acceleration Acquisition
0.0$10.09+1.2%$386.78 millionN/A0.00
HMCO
HumanCo Acquisition
0.0$10.00+0.1%$384.38 millionN/A0.00
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.